As part of the more than $30 million that Withings is investing in expanding its service offerings, the company announced today that it had purchased a fitness and wellness app called 8fit.
8fit, a band headquartered in Berlin with twenty members, has performed since 2014. The software developed by the company is intended to provide users with nutritional guidance in addition to a wide variety of simple, healthy meals that can be incorporated into a personalized diet plan. The software also enables users to access hundreds of guided and individualized workouts, including those that focus on high-intensity interval training (HIIT), boxing, Pilates, yoga, and meditation. Since Withings does not already have either of these options, it is clear that they would benefit greatly from making this deal.
8fit is a well-established participant in this market, with more than 40 million app downloads to its name. 8fit and Withings are both companies with a vision centered on the concept of long-term wellness.
Following closely on the heels of the French company’s acquisition of Imputo Medical in January is the latest development. This company is another French company specializing in medical equipment production. Their technology for monitoring peripheral neuropathies is what made them famous in the first place. The technology, which has been given the name SUDOSCAN, employs an electrical stimulus to evaluate the response of the sweat glands in the palms and soles.
To refresh your memory, Withings announced at CES 2022 that it would be releasing a new smart scale called the Body Scan. This scale can monitor nerve activity, Afib, and segmental body composition. The first of these makes use of the technology known as imputing medicine. An examination of nerve activity has the ability to detect specific illnesses, including diabetes.
Withings is the industry leader when it comes to smart scales. Back in 2009, this company was credited with developing the very first product of its kind. It is anticipated that the Body Scan smart scale will make its debut on the market in the latter part of 2022. Once the item is commercially available, we will prioritize trying to get our hands (and feet) on it so that we can provide a comprehensive assessment of it.
Withings is making both acquisitions part of an effort to expand its presence outside the ecosystem of devices it already possesses. It would appear that the corporation is considering developing a software product that is sold on a subscription basis in order to generate an additional source of revenue for itself. Essentially, Withings wants to combine the personal health data recorded by its smartwatches, blood pressure monitors, and smart scales with individualized wellness regimens to improve its customers’ overall health.
There is a sizable customer base for products like that, which is why companies like Apple and Fitbit have already started down this road. The French company has more than $30 million set aside to be invested over the course of the next three years in order to speed up the development of its offering. Although the precise sum that will be used for the 9fit transaction has not been made public, a portion of this will be spent on it.